Pembrolizumab in the first line treatment of recurrent and/or metastatic head & neck cancer

Date 14 March 2019
Event 7th ICHNO - International Conference on Innovative Approaches in Head and Neck Oncology
Session Late breaking news
Topics Head and Neck Cancers
Immunotherapy
Presenter Barbara Burtness (US)